The global market for liquid embolics was estimated to be worth around $130 million in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 1.4% during the forecast period, reaching a value of $145 million. The complete report suite on the global liquid embolics market covers only liquid embolics.
Stryker held the top position in the global detachable coil market in 2022, with a particular emphasis on the bare platinum segment. The GDC® 360° detachable coil, a treatment for neurovascular aneurysm occlusion, is widely considered the gold standard and has played a pioneering role in advancing endovascular treatment for intracranial aneurysms.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2029, and Historical Data to 2019
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL LIQUID EMBOLIC MARKET INSIGHTS
One of the main factors driving the global liquid embolic market is the less invasive nature of the treatment, which does not require open surgery, resulting in reduced patient recovery time. In contrast, coiling procedures still face challenges that could restrict market expansion, such as complications including catheter entrapment leading to serious issues such as hemorrhage, death, or migration of catheter fragments to other parts of the body.GLOBAL LIQUID EMBOLIC MARKET SHARE INSIGHTS
Within the global market for liquid embolics, there are three key market players - Medtronic, Cerenovus, and MicroVention.Stryker held the top position in the global detachable coil market in 2022, with a particular emphasis on the bare platinum segment. The GDC® 360° detachable coil, a treatment for neurovascular aneurysm occlusion, is widely considered the gold standard and has played a pioneering role in advancing endovascular treatment for intracranial aneurysms.
MARKET SEGMENTATION SUMMARY
- Global Liquid Embolic Market
RESEARCH SCOPE SUMMARY
- Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
- Base Year: 2022
- Forecast: 2023-2029
- Historical Data: 2019-2022
- Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
- Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
- Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, Internal Database.
Table of Contents
- Liquid Embolic Market
- Executive Summary
- Global Liquid Embolic Market Overview
- Competitive Analysis
- Regions Included
- Introduction
- Procedure Numbers
- Market Analysis and Forecast
- Drivers and Limiters
- Market Drivers
- Market Limiters
- Competitive Market Share Analysis
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Medtronic
- Cerenovus
- MicroVention
- Balt
- LivaNova
- Meril
